Image of Oral antiplatelet therapy for acute ischaemic stroke (Review)

LITERATURE

Oral antiplatelet therapy for acute ischaemic stroke (Review)


In people with acute ischaemic stroke, platelets become activated and can cause blood clots to form and block an artery in the brain,
resulting in damage to part of the brain. Such damage gives rise to the symptoms of stroke. Antiplatelet therapy might reduce the volume
of brain damaged by ischaemia and also reduce the risk of early recurrent ischaemic stroke, thereby reducing the risk of early death and
improving long-term outcomes in survivors. However, antiplatelet therapy might also increase the risk of fatal or disabling intracranial
haemorrhage.


Availability

REQJ4499Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD000029.
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous